openPR Logo
Press release

Multiple Sclerosis Drugs and Treatment Market to Grow At A CAGR Of 6% On Account Of Growing Awareness for the Disorder By 2027 | Leading Players Bayer AG (BAYN), Novartis AG (NOVN), Biogen (BIIB), Genzyme Corporation

01-23-2020 12:44 PM CET | Health & Medicine

Press release from: Research Nester

Multiple Sclerosis Drugs and Treatment Market to Grow At A CAGR

Research Nester Released a Report titled “Multiple Sclerosis Drugs and Treatment Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global multiple sclerosis drugs and treatment market in terms of market segmentation by drug, by route of administration, by distribution channel and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Multiple sclerosis is an autoimmune disease that affects the central nervous system (CNS) of the body that mainly consists of the brain and spinal cord. It is a chronic health disorder that leads to the damage of nerves, thereby disrupting the communication between the brain and other parts of the body. The market for multiple sclerosis drugs and treatment is anticipated to grow at a significant CAGR of about 6% during the forecast period, i.e., 2019-2027. The market is segmented by drug, by route of administration, by distribution channel and by region. On the basis of drug, the market is further segmented into interferons, immunomodulators and immunosuppressants, out of which, the segment for immunomodulatory drugs is estimated to hold a significantly large share in the market during the forecast period. This can be attributed to the development of new methods of treatment for multiple sclerosis that are immunomodulatory in nature.

Click Here to Download Sample Report: – https://www.researchnester.com/sample-request-1986

The market in North America region is anticipated to witness largest share in the market on account of presence of highly advanced medical facilities along with large number of research institutions in the region. Additionally, the high prevalence of multiple sclerosis is another factor contributing towards the market growth. Further, the market in Europe is estimated to hold the second highest share as a result of growing demand for effective therapeutic drugs for the treatment of multiple sclerosis.

Rising Prevalence of Multiple Sclerosis to Boost the Market Growth

As per a journal published by the Lancet Neurology, there were 2,221,188 cases of multiple sclerosis prevalent around the world in 2016. The age-standardized prevalence of this disorder was higher than 120 cases per 100,000 people in North America. On the other hand, it was moderate in some European countries with 60 to 120 cases per 100,000 population and lowest in North Africa, Middle East and Latin America with less than 60 cases per 100,000 people in every region. The increasing prevalence of multiple sclerosis raises the demand for improved treatment methods for the disorder. This is estimated to become a factor responsible for the market growth. On the other hand, the strict government policies regarding the approval of drugs is anticipated to hinder the market growth.

Get Exclusive Research Scope of This Report: – https://www.researchnester.com/sample-request-1986

This report also provides the existing competitive scenario of some of the key players of the global multiple sclerosis drugs and treatment market which includes company profiling of Bayer AG (BAYN), Novartis AG (NOVN), Biogen (BIIB), Genzyme Corporation, F. Hoffmann-La Roche, Teva Pharmaceutical Industries Ltd., Pfizer Inc. (PFE), Merck KGaA (MRK), AbbVie Inc. and Opexa Therapeutics, Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global multiple sclerosis drugs and treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Get more information on this report: https://www.researchnester.com/reports/multiple-sclerosis-drugs-and-treatment-market/1986

AJ Daniel
Email: sales@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiple Sclerosis Drugs and Treatment Market to Grow At A CAGR Of 6% On Account Of Growing Awareness for the Disorder By 2027 | Leading Players Bayer AG (BAYN), Novartis AG (NOVN), Biogen (BIIB), Genzyme Corporation here

News-ID: 1906103 • Views: 55

More Releases from Research Nester

Global Hydraulic Filters Market Expected to Grow at a CAGR of 3.43% by 2027 | In …
Research Nester released a report titled "Global Hydraulic Filters Market: Global Demand Analysis & Opportunity Outlook 2027" which delivers detailed overview of the global hydraulic filters market in terms of market segmentation by end-use industry, vehicle type, channel, material, type and by region. Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter's five force model. The global hydraulic
Business Intelligence (BI) Vendors Market Projected to Grow at a CAGR of 12.1% b …
Research Nester released a report titled "Business Intelligence (BI) Vendors Market - Global Demand Analysis & Opportunity Outlook 2027" which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market share comparisons, BPS analysis, SWOT analysis and Porter's five force model. The term "Business Intelligence" is defined as a superset of software as a service
Europe Wind Turbine Gearbox Repair and Refurbishment Market Insights Covering Ma …
Research Nester released a report titled "Europe Wind Turbine Gearbox Repair and Refurbishment Market: Regional Demand Analysis & Opportunity Outlook 2027" which delivers detailed overview of the Europe wind turbine gearbox repair and refurbishment market in terms of market segmentation by product, gearbox failure, deployment and by region. Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter's
Smart Pills Market (20.8% CAGR) 2017-2024: Global Industry Insights by Growth, E …
The global smart pills market is segmented into application such as capsule endoscopy, drug delivery and patient monitoring out of which, capsule endoscopy segment dominated the overall smart pills market in 2016 and is projected to capture a noteworthy CAGR of 18.1% by the end of 2024. In addition to this, increased complexity in endoscopy procedures has augmented the demand for capsule endoscopy due to its patient friendly procedure to

All 5 Releases


More Releases for Multiple

Medical Monitoring System Records Multiple Measurement Values
Accsense Monitoring For Cleanrooms, Surgeries & Incubators If you need comprehensive medical monitoring system for temperature or other values, consider Accsense Monitoring, popular for use in hospitals, clinics, pharmacies, and labs. An Accsense Online Monitoring system can continually monitor any healthcare environment from refrigerated medication storage, incubators, cleanroom differential pressure, and patient care areas. These systems can record almost any physical parameter and are also fully compliant with the Joint Commission.
Global Multiple Sclerosis Market Size, Global Multiple Sclerosis Market Share, G …
The Global Multiple Sclerosis Market Size is majorly driven by the factors such as rising number of consolidations between the market players for exploring the untapped market opportunity across the world. Request for Sample of This Research Report @ https://bit.ly/2Nh6b4d Top Key Player:- Hoffmann-La Roche Ltd. Bayer Healthcare AG Teva Pharmaceuticals GlaxoSmithKline AbbVie Inc. Sonafi Pasteur Pfizer Inc. Merck & Company Novartis AG AB Science Opexa Multiple Sclerosis (MS) is a disease in which the insulating covers of nerves and spinal cord are
Thermoseal Group Multiple Award Winners
For the second year in a row, Thermoseal Group is the winner of the coveted Glass and Glazing Industry’s G-Award for ‘Component Supplier of the Year’ as announced at the prestigious Gala Dinner held at the Hilton on Park Lane Hotel in London on Friday 18 November 2016. This was a great day for Thermoseal Group who were also announced winners at two other awards events held that day
Reduce Headaches Updating Multiple Spreadsheets
Melbourne, Australia – DataMystic announces ExcelPipe 7.5, its enhanced mass-replacement utility for Microsoft Excel. Do you make the same change to a group of Excel Spreadsheets, over and over again? End of calendar year? End of financial year? And you know how tedious that is? ExcelPipe is a time-saving search and replace tool designed to work hand-in-hand with Microsoft Excel to change thousands of Spreadsheets automatically. It saves weeks of manual labor
Reduce Headaches Updating Multiple Documents
Reduce Headaches Updating Multiple Documents Melbourne, Australia – DataMystic announces WordPipe 9.4, its enhanced mass-replacement utility for Microsoft Word. Do you make the same change to a group of Word documents, over and over again? And you know how tedious that is? WordPipe is a time-saving search and replace tool designed to work hand-in-hand with Microsoft Word to change thousands of documents automatically. It saves weeks of manual labor when links need changing,
Formulating Cosmetics For Multiple Markets
With all the regulatory information and expertise available, it’s worth considering the destination markets where you want to sell a product as the basis for the formulation you use. For example, when formulating products destined for the US market, you should consider the demands of federal and state legislation – in as many states as you want to sell into. If California is one of them, you need to know if